Grantham, Mayo, Van Otterloo & Co (GMO)
ANGO icon

Grantham, Mayo, Van Otterloo & Co (GMO)’s AngioDynamics ANGO Stock Holding History

Grantham, Mayo, Van Otterloo & Co (GMO)’s Portfolio ANGO Stock Details ANGO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-87,100
Closed -$1.33M – 837
2020
Q4 		$1.33M Sell
87,100
-82,000
-48% -$1.04M 0.01% 517
2020
Q3 		$2.04M Buy
169,100
+3,800
+2% +$36.1K 0.01% 405
2020
Q2 		$1.68M Buy
165,300
+151,500
+1,098% +$1.56M 0.01% 446
2020
Q1 		$144K Buy
+13,800
New +$173K ﹤0.01% 719

Other funds holding ANGO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
SFM
Systematic Financial Management Teaneck, New Jersey $4.36B AUM 40.56% 1-Year Est. Return

Grantham, Mayo, Van Otterloo & Co (GMO)'s ANGO Position: Q1 2021 in Review

Grantham, Mayo, Van Otterloo & Co (GMO) sold out of AngioDynamics (ANGO) in Q1 2021, closing a stake of 87,100 shares — an estimated $1.33M sold.

Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in ANGO in Q1 2020 and held it in 4 quarters. The position peaked at $2.04M in Q3 2020. 144 funds tracked by Wall St. Rank hold ANGO as of Q1 2021.

  • Grantham, Mayo, Van Otterloo & Co (GMO) reported no remaining AngioDynamics position as of Q1 2021 after selling out during the quarter.
  • Grantham, Mayo, Van Otterloo & Co (GMO) sold 87,100 AngioDynamics shares in Q1 2021, an estimated $1.33M.
  • Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in AngioDynamics in Q1 2020 and held it in 4 quarters.
  • Grantham, Mayo, Van Otterloo & Co (GMO)'s AngioDynamics position peaked at $2.04M in Q3 2020.
  • 144 funds tracked by Wall St. Rank held AngioDynamics as of Q1 2021.

Based on Grantham, Mayo, Van Otterloo & Co (GMO)'s 13F filing for Q1 2021, filed 13 May 2021.